SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-054732
Filing Date
2023-11-08
Accepted
2023-11-08 18:08:22
Documents
1
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 24931
  Complete submission text file 0001209191-23-054732.txt   26411
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT PKWY SOUTH SAN FRANCISCO CA 94080
Business Address
Lieu Hsiao D (Reporting) CIK: 0001468482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 231389482